Purchase 2-Oxo-PCM
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 2-Oxo-PCM for sale
Deschloroketamine (DXE) is a dissociative anaesthetic that acts as a PCM. It has been sold online as a designer drug. It has also been proposed for use in treating bacterial, fungal, viral or protozoal infections at doses of 2 mg per day.
Deschloroketamine (brand name Ketalar ) is an anaesthetic drug for surgery administered by intravenous injection. It has also been proposed for use in treating bacterial, fungal, viral or protozoal infections at doses of 2 mg per day.
Deschloroketamine, also known as DXE, is a new dissociative anaesthetic under experimental treatment to suppress infections caused by fungi and possibly protozoa.
Deschloroketamine is a psychoactive drug of the arylcyclohexylamine class. It is similar in structure and effects to ketamine, PCE and eticyclidine (PCE).
Deschloroketamine is a drug that acts as an NMDA receptor antagonist.
Numerous reports suggest that DXE may be useful in treating chronic pain, depression, and cluster headaches.
2-Oxo-PCM is a hallucinogenic dissociative anaesthetic sold online as a designer drug. It has also been proposed for treating bacterial and protozoal infections and immunomodulation at doses of 2 mg per day.
Deschloroketamine (DXE, DCK) is a dissociative anaesthetic sold online as a designer drug but has never been formally tested or prescribed for any condition. The drug was previously scheduled internationally but was suddenly delisted in many countries and then rescheduled to a lower class in the United States.
Deschloroketamine (DXE, DCK) is a dissociative anaesthetic sold online as a designer drug. While it was previously scheduled internationally, it was suddenly delisted in many countries and rescheduled to a lower class in the United States.
Deschloroketamine, also known as DCK or "diphenidine", is a hallucinogenic dissociative substance of the arylcyclohexylamine class that produces dissociative and hallucinogenic effects when administered. It has been sold online as a recreational designer drug but has never been formally tested or prescribed for any condition. The drug was previously scheduled internationally but was suddenly delisted in many countries and then rescheduled to a lower class in the United States.
Diphenidine is an arylcyclohexylamine hallucinogen that produces dissociative and hallucinogenic effects when administered. It has been sold online as a recreational designer drug but has never been formally tested or prescribed for any condition. The drug was previously scheduled internationally but was suddenly delisted in many countries and then rescheduled to a lower class in the United States.
Deschloroketamine, sometimes known by its street names Diphenidine, 2'-Oxo-PCE (also personalised on request) or incorrectly as 2'-Oxo-PCM or 2'-Oxo-4-Chlorophenethylamine, is a potent dissociative substance of the arylcyclohexylamine class that produces powerful dissociative and hallucinogenic effects when administered. It has been sold online as a recreational designer drug but has never been formally tested or prescribed for any condition. The drug was previously scheduled internationally but was suddenly delisted in many countries and then rescheduled to a lower class in the United States in May 2016.
Dissociative drugs are psychoactive substances that induce an out-of-body experience by distorting the perception of sight and sound. They can also lead to hallucinations, depending on their strength. Among these is piperidine, a new designer drug sold on the internet as a "research chemical".
Deschloroketamine contains a hallucinogen-like chemical called ketamine, but at quantities so low that it doesn't produce the same "high" as regular use of ketamine. It is currently legally sold without a prescription in the United States.
Deschloroketamine has been sold online in powder, capsules and tablets. The drug is also known by various street names such as "Keta", "Jet", and "Super C".
As Deschloroketamine has never been formally tested or prescribed, very little is known about the drug and its effects.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics